.png)
.png)
Associate Professor Pediatrics
Children's Mercy Hospital
Disclosure(s): No financial relationships to disclose
Dr. Jennifer Goldman, MD, MSCR is currently an Associate Professor of Pediatrics at the University of Missouri – Kansas City with appointments in the Divisions of Pediatric Infectious Diseases and Clinical Pharmacology at Children’s Mercy Kansas City. She serves as the medical director of both the Antimicrobial Stewardship Program and Drug Safety Service at Children’s Mercy. Her clinical and research efforts are centered around individualizing antimicrobial treatment in children to avoid the unintended consequences of anti-infectives. She is investigating potential biomarkers that may predict and prevent severe adverse drug reactions. She works with an amazing team to identify underreported adverse drug reactions, determine the epidemiology of these reactions, and investigate the biochemical and genetic factors associated with reaction risk. Her research is supported by the National Institutes of Health. She currently serves as the Pediatric Health Organization Representative on the Pediatric Advisory Committee for the Food and Drug Administration. During the COVID-19 pandemic, she has become very involved working with educational systems serving as a regional expert related to COVID-19 – focused on the well-being of children and how to help facilitate a safe return to school. She is currently working with the National Institutes of Health to help determine how COVID-19 testing can best be effectively integrated into schools.